Continuous subcutaneous delivery of exenatide via ITCA 650 leads to sustained glycemic control and weight loss for 48 weeks in metformin-treated subjects with type 2 diabetes
| Image |  |
|---|---|
| Description | scientific article published on 7 January 2014 |
| Author/s |
author: Julio Rosenstock |
| Publication date | January 7, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |